What is a space company worth when the yardstick for the entire sector has just been recalibrated? That is the question hanging over Rocket Lab USA as it prepares for a landmark entrance into the Nasdaq-100 while simultaneously grappling with the gravitational pull of SpaceX’s record-breaking public debut.
The timing is awkward. On June 12, SpaceX listed and surged 28 per cent on its first day, reaching a valuation north of $2 trillion. The immediate aftermath was a rotation out of smaller space names. Rocket Lab fell roughly 8 per cent that day. Intuitive Machines tumbled 11 per cent, and AST SpaceMobile shed more than 12 per cent. The pattern was unmistakable: investors cleared space in their portfolios for the industry’s new heavyweight.
By June 19, Rocket Lab’s stock had stabilised near $107, but the day’s range of $101 to $111—a swing of over nine per cent—and trading volume of around 70 million shares betrayed deep uncertainty about where fair value lies. The volatility was not panic, but it was real discomfort.
Into that unsettled environment steps the Nasdaq-100 inclusion, effective before the market opens on Monday. Index membership is a structural event, not a narrative one. Passive investors—Invesco’s flagship ETF, among others—will mechanically add the stock to their portfolios. The shift moves Rocket Lab from a speculative space story into the machinery of large-cap tech. The company’s shareholder base will broaden overnight. The operational risk does not disappear, but the audience changes radically.
Should investors sell immediately? Or is it worth buying Rocket Lab USA?
Yet prestige alone does not substitute for profits. Rocket Lab has already built a credible financial track record. First-quarter 2026 revenue hit $200 million, up from $123 million a year earlier. The net loss narrowed to $45 million, and the GAAP gross margin reached a record 38.2 per cent. The backlog stands at $2.2 billion, supported by more than 70 firm launch commitments. Liquidity exceeds $2 billion.
The valuation, however, remains a sticking point. At the current market capitalisation of roughly $65 billion, the stock trades at an enterprise value-to-revenue multiple of about 81 times annualised first-quarter sales. That is expensive for a company still reporting losses, even after the recent pullback. The Nasdaq-100 entrance brings a broader investor base but also raises the bar: the stock will now be judged against some of the world’s most profitable, scaled technology giants.
Second-quarter guidance offers a near-term test. Rocket Lab expects revenue between $225 million and $240 million, gross margin in the range of 33 to 35 per cent, and adjusted EBITDA of negative $20 million to negative $26 million. Hitting those targets would support the thesis that operational improvements can support the multiple. Missing them would intensify scrutiny—especially now that SpaceX provides a daily, live comparison.
The index upgrade is a milestone, not a finish line. It amplifies visibility and forces institutional attention, but it does not build rockets or guarantee margins. Rocket Lab’s real exam begins Monday, when the stock trades not as a niche space bet, but as a member of the technology elite. The pressure will be more unforgiving, and the operational proof points must follow.
Ad
Rocket Lab USA Stock: Buy or Sell?! New Rocket Lab USA Analysis from June 19 delivers the answer:
The latest Rocket Lab USA figures speak for themselves: Urgent action needed for Rocket Lab USA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 19.
Rocket Lab USA: Buy or sell? Read more here...
